Business
BIOEX: Licensing progress and new capital position Bioextrax for commercial breakthroughs in bioplastics
BIOEX: Licensing progress and new capital position Bioextrax for commercial breakthroughs in bioplastics
About this update from Bioextrax Ab
Net sales and license income declined year-over-year, but cost reductions improved operating results. Major licensing deals and a successful rights issue strengthen liquidity, with the company targeting commercial agreements to reach positive cash flow.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.